BioAge Labs Q1 2026 Earnings EPS Beat on Lower Loss PreRevenue Stage Continues MPWR Q1 2026 Earnings Strong EPS Beat Amid Solid Demand Actinium Pharmaceuticals ATNM Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Advances Continue HOLX Q1 2026 Earnings EPS Falls Short of Expectations by 645 ACN Q1 2026 Earnings EPS Beats Estimates by 213 Amid Consulting Demand SCHL Q1 2026 Earnings NarrowerThanExpected Loss Lifts Sentiment